Tsuyoshi Yoshimoto

1.6k total citations
34 papers, 1.3k citations indexed

About

Tsuyoshi Yoshimoto is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Tsuyoshi Yoshimoto has authored 34 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Epidemiology, 15 papers in Hepatology and 7 papers in Surgery. Recurrent topics in Tsuyoshi Yoshimoto's work include Liver Disease Diagnosis and Treatment (13 papers), Hepatitis C virus research (9 papers) and Intracerebral and Subarachnoid Hemorrhage Research (3 papers). Tsuyoshi Yoshimoto is often cited by papers focused on Liver Disease Diagnosis and Treatment (13 papers), Hepatitis C virus research (9 papers) and Intracerebral and Subarachnoid Hemorrhage Research (3 papers). Tsuyoshi Yoshimoto collaborates with scholars based in Japan, United States and India. Tsuyoshi Yoshimoto's co-authors include Makoto Nakamuta, Munechika Enjoji, Naohiko Harada, Tatsuya Fujino, Kazuhiro Kotoh, Motoyuki Kohjima, Ryoko Yada, Masayoshi Yada, Masaki Kato and Nobito Higuchi and has published in prestigious journals such as Journal of Hepatology, Neurosurgery and Journal of Pharmaceutical Sciences.

In The Last Decade

Tsuyoshi Yoshimoto

32 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tsuyoshi Yoshimoto Japan 13 826 399 397 224 212 34 1.3k
Patricia Aspichueta Spain 21 778 0.9× 366 0.9× 585 1.5× 160 0.7× 261 1.2× 51 1.5k
María E. Miquilena-Colina Spain 14 1.0k 1.3× 361 0.9× 449 1.1× 178 0.8× 209 1.0× 16 1.5k
Bubu A. Banini United States 14 958 1.2× 427 1.1× 375 0.9× 308 1.4× 221 1.0× 37 1.3k
Fahrettin Haczeyni Australia 8 939 1.1× 281 0.7× 654 1.6× 285 1.3× 224 1.1× 8 1.4k
C. Rychlicki Italy 15 771 0.9× 441 1.1× 519 1.3× 293 1.3× 260 1.2× 29 1.4k
C. Candelaresi Italy 20 952 1.2× 505 1.3× 587 1.5× 478 2.1× 259 1.2× 31 1.8k
Cristiana Bertolani Italy 12 1.0k 1.3× 251 0.6× 265 0.7× 514 2.3× 223 1.1× 15 1.5k
Geoff Farrell Australia 11 1.2k 1.5× 490 1.2× 310 0.8× 516 2.3× 162 0.8× 15 1.5k
Wilhelmus J. Kwanten Belgium 18 1.0k 1.2× 356 0.9× 186 0.5× 375 1.7× 205 1.0× 33 1.3k
Takuya Kitada Japan 15 690 0.8× 199 0.5× 331 0.8× 405 1.8× 217 1.0× 40 1.2k

Countries citing papers authored by Tsuyoshi Yoshimoto

Since Specialization
Citations

This map shows the geographic impact of Tsuyoshi Yoshimoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tsuyoshi Yoshimoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tsuyoshi Yoshimoto more than expected).

Fields of papers citing papers by Tsuyoshi Yoshimoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tsuyoshi Yoshimoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tsuyoshi Yoshimoto. The network helps show where Tsuyoshi Yoshimoto may publish in the future.

Co-authorship network of co-authors of Tsuyoshi Yoshimoto

This figure shows the co-authorship network connecting the top 25 collaborators of Tsuyoshi Yoshimoto. A scholar is included among the top collaborators of Tsuyoshi Yoshimoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tsuyoshi Yoshimoto. Tsuyoshi Yoshimoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Komori, Keishi, Yorinobu Sumida, Tsuyoshi Yoshimoto, et al.. (2020). [A case of swallow syncope with transient congestive liver caused by esophageal dilatation associated with huge hiatal hernia].. PubMed. 117(10). 907–913. 1 indexed citations
2.
Kohjima, Motoyuki, Munechika Enjoji, Tsuyoshi Yoshimoto, et al.. (2016). Analysis of renal function during telaprevir-based triple therapy for chronic hepatitis C. Experimental and Therapeutic Medicine. 11(5). 1781–1787. 1 indexed citations
3.
Kohjima, Motoyuki, Tsuyoshi Yoshimoto, Munechika Enjoji, et al.. (2015). Hepcidin/ferroportin expression levels involve efficacy of pegylated-interferon plus ribavirin in hepatitis C virus-infected liver. World Journal of Gastroenterology. 21(11). 3291–3299. 11 indexed citations
4.
Yoshino, Keisuke, Koji Nakamura, Yoshihiko Abe, et al.. (2014). Functional Evaluation and Characterization of a Newly Developed Silicone Oil-Free Prefillable Syringe System. Journal of Pharmaceutical Sciences. 103(5). 1520–1528. 55 indexed citations
5.
Nakamuta, Makoto, Naoko Ishikawa, Ohki Saitoh, et al.. (2013). Genetic polymorphisms of OCT-1 confer susceptibility to severe progression of primary biliary cirrhosis in Japanese patients. Journal of Gastroenterology. 49(2). 332–342. 14 indexed citations
6.
Fujino, Tatsuya, Yoko Aoyagi, Mariko Takahashi, et al.. (2013). Association of ITPA polymorphism with outcomes of peginterferon-α plus ribavirin combination therapy. World Journal of Gastrointestinal Pharmacology and Therapeutics. 4(3). 54–54. 5 indexed citations
7.
Fukushima, Nobuyoshi, Takahiro Mizutani, Kazuhiro Haraguchi, et al.. (2012). [A case of protein-losing gastroenteropathy accompanied by Sjögren syndrome and mixed connective tissue disease].. PubMed. 109(10). 1770–5. 5 indexed citations
8.
Ikeda, Hirofumi, Shuji Matsuura, Tsuyoshi Yoshimoto, et al.. (2012). A case of hepatic portal venous gas in a hemodialysis patient undergoing tube feeding. Nihon Toseki Igakkai Zasshi. 45(8). 651–656. 1 indexed citations
9.
Nakamuta, Makoto, Ryoko Yada, Yoko Aoyagi, et al.. (2011). Expression profiles of genes associated with viral entry in HCV‐infected human liver. Journal of Medical Virology. 83(5). 921–927. 14 indexed citations
10.
Fujino, Tatsuya, Makoto Nakamuta, Ryoko Yada, et al.. (2010). Expression profile of lipid metabolism‐associated genes in hepatitis C virus‐infected human liver. Hepatology Research. 40(9). 923–929. 35 indexed citations
11.
Nakamuta, Makoto, Ryoko Yada, Kaori Yasutake, et al.. (2010). Therapeutic effect of bezafibrate against biliary damage: a study of phospholipid secretion via the PPARalpha-MDR3 pathway. International Journal of Clinical Pharmacology and Therapeutics. 48(1). 22–28. 17 indexed citations
12.
Fujino, Tatsuya, Makoto Nakamuta, Yoko Aoyagi, et al.. (2009). Early decline of the HCV core antigen can predict SVR in patients with HCV treated by Pegylated interferon plus ribavirin combination therapy. Journal of Digestive Diseases. 10(1). 21–25. 8 indexed citations
13.
Enjoji, Munechika, Ryoko Yada, Tatsuya Fujino, et al.. (2009). The state of cholesterol metabolism in the liver of patients with primary biliary cirrhosis: the role of MDR3 expression. Hepatology International. 3(3). 490–496. 14 indexed citations
14.
Nakamuta, Makoto, Yoko Aoyagi, Tatsuya Fujino, et al.. (2009). Validity of FibroScan values for predicting hepatic fibrosis stage in patients with chronic HCV infection. Journal of Digestive Diseases. 10(2). 145–148. 23 indexed citations
15.
Yasutake, Kenichiro, Makoto Nakamuta, Kaori Masuda, et al.. (2008). Nutritional investigation of non-obese patients with non-alcoholic fatty liver disease: The significance of dietary cholesterol. Scandinavian Journal of Gastroenterology. 44(4). 471–477. 173 indexed citations
16.
Yoshimoto, Tsuyoshi, Kazuhiro Kotoh, Motoyuki Kohjima, et al.. (2007). Decreased portal flow volume increases the area of necrosis caused by radio frequency ablation in pigs. Liver International. 27(3). 368–372. 7 indexed citations
17.
Nakamuta, Makoto, Motoyuki Kohjima, Shusuke Morizono, et al.. (2006). Comparison of tissue pressure and ablation time between the LeVeen and cool-tip needle methods. PubMed. 5(1). 10–10. 16 indexed citations
18.
Morizono, Shusuke, Makoto Nakamura, Motoyuki Kohjima, et al.. (2004). [Evaluation of acute hepatic failure treated at the Department of Medicine III, Kyushu University Hospital: indications for living-donor liver transplantation].. PubMed. 95(12). 321–31. 2 indexed citations
19.
Karibe, Hiroyuki, et al.. (2001). Hepatitis C virus (HCV) infection as a risk factor for spontaneous intracerebral hemorrhage: hospital based case-control study. Journal of Clinical Neuroscience. 8(5). 423–425. 14 indexed citations
20.
Mizoi, Kazuo, Tsuyoshi Yoshimoto, Shinsuke Fujiwara, et al.. (1991). Prevention of vasospasm by clot removal and intrathecal bolus injection of tissue-type plasminogen activator. Neurosurgery. 28(6). 807–807. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026